These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Intravitreal Bevacizumab for Traumatic Choroidal Rupture. Kim M; Kim JH; Seo Y; Koh HJ; Lee SC Optom Vis Sci; 2015 Oct; 92(10):e363-7. PubMed ID: 26367340 [TBL] [Abstract][Full Text] [Related]
5. Photoreceptor reconstitution correlates with visual improvement after intravitreal bevacizumab treatment of choroidal neovascularization secondary to traumatic choroidal rupture. Francis JH; Freund KB Retina; 2011 Feb; 31(2):422-4. PubMed ID: 21240036 [No Abstract] [Full Text] [Related]
6. Long-term outcomes of intravitreal antivascular endothelial growth factor therapy for the management of choroidal neovascularization in pseudoxanthoma elasticum. Myung JS; Bhatnagar P; Spaide RF; Klancnik JM; Cooney MJ; Yannuzzi LA; Freund KB Retina; 2010 May; 30(5):748-55. PubMed ID: 19996818 [TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab treatment of bilateral peripapillary choroidal neovascularization from optic nerve head drusen. Knape RM; Zavaleta EM; Clark CL; Khuddus N; Peden MC J AAPOS; 2011 Feb; 15(1):87-90. PubMed ID: 21397813 [TBL] [Abstract][Full Text] [Related]